Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
This gene refers to a pseudogene homologous to the protein-coding NSA2, which is involved in ribosome biogenesis and cell proliferation in its functional form. Pseudogenes are typically noncoding genomic sequences similar to known genes but lack protein-coding potential. Recent research suggests some pseudogenes can influence cellular biology by generating noncoding RNAs that regulate coding gene expression, either by producing antisense transcripts, competing for regulatory factors, or being processed into small interfering RNAs. There is no evidence that this NSA2 pseudogene has a direct protein-encoded function, nor is it a therapeutic target, but pseudogenes as a class are being studied for their potential roles in gene regulation and disease.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosome biogenesis protein NSA2 homolog pseudogene.